Medpace Holdings, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 44.11K shares, a 633.96% increase year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 92.27K shares, a 76.83% decline year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 150.30K shares, a 282.63% increase year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 85.16K shares, a 20.58% increase year-over-year.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 639.73K shares, a 132.85% increase from fiscal 2024.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 274.73K shares, a 4.29% decline from fiscal 2023.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 287.05K shares, a 50.46% decline from fiscal 2022.
- Medpace Holdings, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 579.41K shares, a 22.29% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 44.11K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-23 | 371.84K shares derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | 92.27K shares 10-Q · filed 2026-04-23 | 333.74K shares derived: sum of 4 quarters · filed 2026-04-23 |
| 2025-12-31 | 150.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | 639.73K shares 10-K · filed 2026-02-10 |
| 2025-09-30 | 85.16K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-23 | 528.71K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2025-06-30 | 6.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-22 | 514.17K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2025-03-31 | 398.25K shares 10-Q · filed 2025-04-22 | 524.06K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-12-31 | 39.28K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | 274.73K shares 10-K · filed 2026-02-10 |
| 2024-09-30 | 70.63K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-22 | 284.01K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-06-30 | 15.90K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-23 | 322.76K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-03-31 | 148.92K shares 10-Q · filed 2024-04-23 | 367.98K shares derived: sum of 4 quarters · filed 2026-02-10 |
| 2023-12-31 | 48.56K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | 287.05K shares 10-K · filed 2026-02-10 |
| 2023-09-30 | 109.38K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-24 | 422.04K shares derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-06-30 | 61.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-25 | 346.41K shares derived: sum of 4 quarters · filed 2025-02-11 |
| 2023-03-31 | 67.99K shares 10-Q · filed 2023-04-25 | 338.95K shares derived: sum of 4 quarters · filed 2025-02-11 |
| 2022-12-31 | 183.54K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | 579.41K shares 10-K · filed 2025-02-11 |
| 2022-09-30 | 33.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-25 | 463.45K shares derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-06-30 | 53.66K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-26 | 465.49K shares derived: sum of 4 quarters · filed 2024-02-13 |
| 2022-03-31 | 308.45K shares 10-Q · filed 2022-04-26 | 647.85K shares derived: sum of 4 quarters · filed 2024-02-13 |
| 2021-12-31 | 67.59K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-13 | 745.57K shares 10-K · filed 2024-02-13 |
| 2021-09-30 | 35.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-26 | 851.49K shares derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | 236.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-27 | 1.17M shares derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | 406.17K shares 10-Q · filed 2021-04-27 | 963.14K shares derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | 173.51K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | 637.81K shares 10-K · filed 2023-02-14 |
| 2020-09-30 | 349.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27 | 517.85K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-06-30 | 34.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 286.20K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2020-03-31 | 80.83K shares 10-Q · filed 2020-04-29 | 417.12K shares derived: sum of 4 quarters · filed 2022-02-15 |
| 2019-12-31 | 53.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | 399.37K shares 10-K · filed 2022-02-15 |
| 2019-09-30 | 117.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-29 | 394.25K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | 165.06K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-30 | 319.19K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | 63.08K shares 10-Q · filed 2019-04-30 | 194.69K shares derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | 48.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | 169.77K shares 10-K · filed 2021-02-16 |
| 2018-09-30 | 42.62K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-30 | 154.45K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | 40.55K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31 | 122.92K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | 38.16K shares 10-Q · filed 2018-05-01 | 142.26K shares derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | 33.11K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 116.79K shares 10-K · filed 2020-02-25 |
| 2017-09-30 | 11.10K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | |
| 2017-06-30 | 59.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | |
| 2017-03-31 | 12.69K shares 10-Q · filed 2017-05-02 | |
| 2016-12-31 | 36.98K shares 10-K · filed 2019-02-26 | |
| 2015-12-31 | 17.40K shares 10-K · filed 2018-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |